Journal of Veterinary Pharmacology & Therapeutics

Pharmacokinetics of oral doxycycline and concentrations in body fluids and bronchoalveolar cells of foals
pp. 187-193(7)
Authors: WOMBLE, A.; GIGUÈRE, S.; LEE, E. A.

Cetirizine in horses: pharmacokinetics and effect of ivermectin pretreatment
pp. 194-200(7)
Authors: OLSÉN, L.; INGVAST-LARSSON, C.; BONDESSON, U.; BROSTRÖM, H.; TJÄLVE, H.; LARSSON, P.

Clinical signs and etiology of adverse reactions to procaine benzylpenicillin and sodium/potassium benzylpenicillin in horses
pp. 201-207(7)
Authors: OLSÉN, L.; INGVAST-LARSSON, C.; BROSTRÖM, H.; LARSSON, P.; TJÄLVE, H.

Pharmacokinetics and metabolism of orally administered firocoxib, a novel second generation coxib, in horses
pp. 208-217(10)
Authors: KVATERNICK, V.; POLLMEIER, M.; FISCHER, J.; HANSON, P. D.

Evaluation of the adverse effects of oral firocoxib in healthy dogs
pp. 218-223(6)
Authors: STEAGALL, P. V. M.; MANTOVANI, F. B.; FERREIRA, T. H.; SALCEDO, E. S.; MOUTINHO, F. Q.; LUNA, S. P. L.

Pharmacokinetics and physiological effects of two intravenous infusion rates of morphine in conscious dogs
pp. 224-233(10)
Authors: GUEDES, A. G. P.; PAPICH, M. G.; RUDE, E. P.; RIDER, M. A.

Meta-analysis of treatment of cattle with bovine respiratory disease with tulathromycin
pp. 234-241(8)
Authors: WELLMAN, N. G.; O'CONNOR, A. M.

Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition
pp. 242-248(7)
Authors: BALLENT, M.; LIFSCHITZ, A.; VIRKEL, G.; SALLOVITZ, J.; LANUSSE, C.

Clinical pharmacology of buprenorphine in healthy, lactating goats
pp. 249-256(8)
Authors: INGVAST-LARSSON, C.; SVARTBERG, K.; HYDBRING-SANDBERG, E.; BONDESSON, U.; OLSSON, K.

Identification and comparison of marbofloxacin metabolites from the plasma of ball pythons (Python regius) and blue and gold macaws (Ara ararauna)
pp. 257-262(6)
Authors: HUNTER, R. P.; KOCH, D. E.; COKE, R. L.; CARPENTER, J. W.; ISAZA, R.

Pharmacokinetics of sodium and trihydrate amoxicillin in sheep after intravenous and intramuscular administration
pp. 263-266(4)
Authors: FERNANDEZ, C.; MODAMIO, P.; MESTORINO, N.; ERRECALDE, J. O.; MARIÑO, E. L.

The safety of tulathromycin administration in goats
pp. 267-270(4)
Authors: WASHBURN, K. E.; BISSETT, W.; FAJT, V.; CLUBB, F.; FOSGATE, G. T.; LIBAL, M.; SMYRE, K. E.; CASS, K. L.

Comparative pharmacokinetics of sulfamethazine after intravenous administration in bovine (Bos taurus) and buffalo (Bubalis bubalis) calves
pp. 271-274(4)
Authors: BARONI, E. E.; DÍAZ, D. C.; PICCO, E.; RUBIO, M.; RODRÍGUEZ, C.; BOGGIO, J. C.; SAN ANDRÉS, M. I.

Therapeutic efficacy and safety of undenatured type-II collagen (UC-II) alone or in combination with (−)-hydroxycitric acid and chromemate in arthritic dogs
pp. 275-278(4)
Authors: PEAL, A.; D'ALTILIO, M.; SIMMS, C.; ALVEY, M.; GUPTA, R. C.; GOAD, J. T.; CANERDY, T. D.; BAGCHI, M.; BAGCHI, D.

Des Hennessy
pp. 279-279(1)